NDC 50090-3372

Shingrix

Zoster Vaccine Recombinant, Adjuvanted

Shingrix is a Kit in the Vaccine category. It is labeled and distributed by A-s Medication Solutions. The primary component is .

Product ID50090-3372_391864b9-e302-4ace-ad3c-049068667e3b
NDC50090-3372
Product TypeVaccine
Proprietary NameShingrix
Generic NameZoster Vaccine Recombinant, Adjuvanted
Dosage FormKit
Marketing Start Date2017-10-20
Marketing CategoryBLA /
Application NumberBLA125614
Labeler NameA-S Medication Solutions
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-3372-0

1 KIT in 1 KIT (50090-3372-0) * .5 mL in 1 VIAL (58160-828-03) * .5 mL in 1 VIAL (58160-829-03)
Marketing Start Date2017-10-20
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Shingrix" or generic name "Zoster Vaccine Recombinant, Adjuvanted"

NDCBrand NameGeneric Name
50090-3372ShingrixZoster Vaccine Recombinant, Adjuvanted
50090-5147ShingrixZoster Vaccine Recombinant, Adjuvanted
58160-819ShingrixZoster Vaccine Recombinant, Adjuvanted
58160-823ShingrixZoster Vaccine Recombinant, Adjuvanted

Trademark Results [Shingrix]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SHINGRIX
SHINGRIX
87271312 not registered Dead/Abandoned
GlaxoSmithKline Biologicals S.A.
2016-12-16
SHINGRIX
SHINGRIX
85169964 3989266 Live/Registered
GlaxoSmithKline Biologicals, S.A.
2010-11-05
SHINGRIX
SHINGRIX
77099952 not registered Dead/Abandoned
GlaxoSmithKline Biologicals, S.A.
2007-02-06
SHINGRIX
SHINGRIX
77095562 not registered Dead/Abandoned
Glaxo Group Limited
2007-01-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.